
In a statement submitted to the House Ways and Means Committee for a hearing May 16 on health care price transparency, AHA recommended Congress and the Administration streamline existing hospital price transparency requirements to reduce potential patient confusion and unnecessary regulatory burden on providers, and refrain from advancing legislation or regulations that make it harder to provide meaningful price estimates.